Used primarily in the treatment of osteoporosis, this compound helps increase bone mass and reduce the risk of fractures, especially in postmenopausal women and men with low bone density. It is also prescribed for Paget's disease of bone, where it helps normalize excessive bone turnover. By inhibiting bone resorption, it strengthens weakened skeletal structures and alleviates bone pain associated with certain metabolic bone disorders. The compound is effective in managing bone complications in patients with glucocorticoid-induced osteoporosis. It is typically administered orally and requires strict dosing instructions to ensure proper absorption and minimize gastrointestinal side effects.